Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
New York Times
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.
https://www.nytimes.com/2025/02/05/business/novo-nordisk-earnings-ozempic-wegovy.html